表紙
市場調查報告書

蛋白質表現市場:按類型(大腸菌、哺乳類、酵母菌、畢赤酵母菌屬、昆蟲、桿狀病毒、無細胞)、產品(試劑、勝任細胞、儀器、服務)、應用、末端使用、區域 - 到2025年的全球市場預測

Protein Expression Market by Type (Escherichia Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus and Cell-free), Products (Reagents, Competent Cells, Instruments, Services), Application, End-User and Region - Global Forecast to 2025

出版商 MarketsandMarkets 商品編碼 936568
出版日期 內容資訊 英文 174 Pages
訂單完成後即時交付
價格
蛋白質表現市場:按類型(大腸菌、哺乳類、酵母菌、畢赤酵母菌屬、昆蟲、桿狀病毒、無細胞)、產品(試劑、勝任細胞、儀器、服務)、應用、末端使用、區域 - 到2025年的全球市場預測 Protein Expression Market by Type (Escherichia Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus and Cell-free), Products (Reagents, Competent Cells, Instruments, Services), Application, End-User and Region - Global Forecast to 2025
出版日期: 2020年05月11日內容資訊: 英文 174 Pages
簡介

預估全球蛋白質表現市場將從2020年的22億美元,以13.2%的CAGR擴大,於2025年成長至41億美元規模。該市場的成長受到多種因素推動,包含慢性病罹病率上升、高齡人口的增加、蛋白質生物製劑需求擴大、生命科學和生物醫藥產業的成長、重組蛋白質表現的研究活動擴大等。新興經濟體可能創造龐大的成長機會;另一方面,對新投入者而言試劑和儀器的高成本阻礙將成為市場成長的課題。產品及服務方面,預估試劑領域將以最高的CAGR成長;區域方面,預估亞太地區將成長最快速。

本報告研究全球蛋白質表現市場,彙整市場概要、按部門趨勢、按區域趨勢、以及參與企業簡介等情報。

第1章 前言

第2章 研究方法

第3章 摘要整理

第4章 PREMIUM見解

第5章 市場概要

  • 簡介
  • 市場趨勢
    • 推動因素
    • 機會
    • 課題
  • COVID-19爆發對蛋白質表現市場成長的影響

第6章 按系統類型的市場

  • 簡介
  • 原核細胞表現系統
  • 哺乳類細胞表現系統
  • 昆蟲細胞表現系統
  • 酵母菌表現系統
  • 無細胞表現系統
  • 藻類表現系統

第7章 按產品及服務的市場

  • 簡介
  • 試劑
  • 表現載體
  • 勝任細胞
  • 儀器
  • 服務

第8章 按應用的市場

  • 簡介
  • 治療應用
  • 工業應用
  • 研究應用

第9章 按末端使用的市場

  • 簡介
  • 製藥與生物科技企業
  • 學術研究機構
  • 其他

第10章 按區域的市場

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第11章 競爭環境

  • 簡介
  • 市場占比分析
  • 競爭領導MAPPING
  • 競爭情勢

第12章 企業簡介

第13章 附錄

目錄
Product Code: BT 2435

"The protein expression market is projected to grow at a CAGR of 13.2% during the forecast period (2020-2025)."

The global protein expression market size is projected to reach USD 4.1 billion by 2025 from USD 2.2 billion in 2020, at a CAGR of 13.2%. The growth of this market is driven majorly by factors such as increasing incidence of chronic diseases, growth in the geriatric population, growing demand for protein biologics, growth in the life science and biopharmaceutical industries, increasing research activities on recombinant based protein expression and availability of funding for protein-based research. Emerging economies are likely to create significant growth opportunities for players in the market. However, the high cost of protein expression reagents and instruments, along with increasing consolidation and high barriers for new entrants, will challenge market growth.

"By product and service, the reagents segment is expected to grow at the highest CAGR during the forecast period."

Based on product and service, the protein expression market is segmented into reagents, expression vectors, competent cells, instruments, and services. The reagents segment accounted for the largest market share in 2019. This segment is also expected to register the highest growth during the forecast period. The large share of this segment is attributed to the increasing research activities in the field of protein expression and the large-scale production of antibodies and vaccines.

"By system type, the prokaryotic expression systems segment dominated the global protein expression market in 2019."

Based on system type, the external protein expression market is segmented into prokaryotic expression systems, mammalian cell expression systems, insect cell expression systems, yeast expression systems, cell-free expression systems, and algal-based expression systems. The prokaryotic expression systems segment accounted for the largest share of the global protein expression industry in 2019, owing to low cost and ease of use of prokaryotic expression systems.

"Asia Pacific protein expression market is expected to witness the highest growth during the forecast period."

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the high incidence of chronic diseases, increasing public and private investments, and an increase in life sciences research.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-29%, Tier 2-37%, and Tier 3-34%
  • By Designation: C-level-35%, Director-level-25%, and Others-40%
  • By Region: North America-35%, Europe-32%, Asia Pacific-22%, RoW-11%

The prominent players operating in the global protein expression market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Genscript Biotech Corporation (US), Takara Bio, Inc. (Japan), Bio-Rad Laboratories (US), Lonza (US), Promega Corporation (US), New England Biolabs (US), Oxford Expression Technologies Ltd. (US), and Synthetic Genomics Inc. (US).

Research Coverage:

The report analyzes the protein expression market and aims at estimating the market size and future growth potential. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the protein expression industry
  • Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the protein expression market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new systems, growing geographies, and recent developments in the global protein expression industry
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and services of leading players in the protein expression market

TABLE OF CONTENTS

1 INTRODUCTION 20

  • 1.1 OBJECTIVES OF THE STUDY 20
  • 1.2 MARKET DEFINITION 21
    • 1.2.1 INCLUSIONS & EXCLUSIONS 21
  • 1.3 MARKET SCOPE 22
    • 1.3.1 MARKETS COVERED 22
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY 22
  • 1.4 CURRENCY 23
  • 1.5 LIMITATIONS 23
  • 1.6 STAKEHOLDERS 23

2 RESEARCH METHODOLOGY 24

  • 2.1 RESEARCH DATA 24
    • 2.1.1 SECONDARY DATA 25
      • 2.1.1.1 Key data from secondary sources 25
    • 2.1.2 PRIMARY DATA 26
      • 2.1.2.1 Key data from primary sources 27
      • 2.1.2.2 Breakdown of primary sources 27
  • 2.2 MARKET SIZE ESTIMATION 28
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 31
  • 2.4 MARKET SHARE ESTIMATION 32
  • 2.5 ASSUMPTIONS FOR THE STUDY 32

3 EXECUTIVE SUMMARY 33

4 PREMIUM INSIGHTS 37

  • 4.1 PROTEIN EXPRESSION MARKET OVERVIEW 37
  • 4.2 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION & COUNTRY (2019) 37
  • 4.3 PROTEIN EXPRESSION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 38

5 MARKET OVERVIEW 39

  • 5.1 INTRODUCTION 39
  • 5.2 MARKET DYNAMICS 39
    • 5.2.1 DRIVERS 40
      • 5.2.1.1 Increasing incidence of chronic diseases 40
      • 5.2.1.2 Growth in the geriatric population 41
      • 5.2.1.3 Increasing demand for protein biologics 42
      • 5.2.1.4 Growth in the life science and biopharmaceutical industries 43
      • 5.2.1.5 Increasing research activities on recombinant-based protein expression 43
      • 5.2.1.6 Availability of funding for protein-based research 44
    • 5.2.2 RESTRAINTS 44
      • 5.2.2.1 High cost of protein expression reagents and instruments 44
      • 5.2.2.2 Increasing consolidation and high barriers for new entrants 45
    • 5.2.3 OPPORTUNITIES 45
      • 5.2.3.1 Emergence of microfluidics 45
      • 5.2.3.2 Emerging economies offer significant growth potential 45
    • 5.2.4 CHALLENGES 46
      • 5.2.4.1 Contamination-A major challenge in protein purification 46
      • 5.2.4.2 Complexities associated with membrane protein expression and purification 46
  • 5.3 THE IMPACT OF COVID-19 OUTBREAK ON THE GROWTH OF THE PROTEIN EXPRESSION MARKET 46
    • 5.3.1 VACCINE AND THERAPY DEVELOPMENT FOR COVID-19 TO BOOST THE MARKET FOR PROTEIN EXPRESSION SYSTEMS 46
    • 5.3.2 INCREASING RESEARCH TO IDENTIFY IDEAL TARGET PROTEINS ON SARS-COV-2 FOR DEVELOPING THERAPIES AS WELL AS DIAGNOSTIC TESTS 47
    • 5.3.3 LOGISTIC CHALLENGES DUE TO SARS-COV-2 MAY RESULT IN DELAY IN PROTEIN EXPRESSION RESEARCH 48
    • 5.3.4 EFFECT OF COVID-19 ON THE PHARMACEUTICAL INDUSTRY 48
    • 5.3.5 PHARMA & BIOTECH COMPANIES ARE DECREASING THEIR DEPENDENCY ON CHINA BY MOVING THEIR MANUFACTURING FACILITIES FROM CHINA TO OTHER PARTS OF THE WORLD 48
    • 5.3.6 INCREASE IN GOVERNMENT FUNDING 49

6 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE 50

  • 6.1 INTRODUCTION 51
  • 6.2 PROKARYOTIC EXPRESSION SYSTEMS 51
    • 6.2.1 ESCHERICHIA COLI SYSTEMS 52
      • 6.2.1.1 Increasing use of E. coli systems for the production of commercial proteins to support market growth 52
    • 6.2.2 OTHER PROKARYOTIC EXPRESSION SYSTEMS 53
  • 6.3 MAMMALIAN CELL EXPRESSION SYSTEMS 53
    • 6.3.1 CHINESE HAMSTER OVARY SYSTEMS 54
      • 6.3.1.1 Chinese hamster ovary systems account for the largest share of the mammalian expression systems market 54
    • 6.3.2 OTHER MAMMALIAN CELL SYSTEMS 55
  • 6.4 INSECT CELL EXPRESSION SYSTEMS 55
    • 6.4.1 BACULOVIRUS SYSTEMS 56
      • 6.4.1.1 Baculovirus systems show high yield and expression level, especially for intracellular proteins 56
    • 6.4.2 OTHER INSECT CELL SYSTEMS 57
  • 6.5 YEAST EXPRESSION SYSTEMS 57
    • 6.5.1 K. LACTIS SYSTEMS 58
      • 6.5.1.1 K. lactis systems held the largest share of the yeast expression systems market in 2019 58
    • 6.5.2 SACCHAROMYCES SYSTEMS 59
      • 6.5.2.1 Saccharomyces systems channelize the direction of foreign proteins into secretory pathways using various signals 59
    • 6.5.3 PICHIA SYSTEMS 60
      • 6.5.3.1 Pichia systems are used for the production of antifreeze proteins and lytic enzymes 60
    • 6.5.4 OTHER YEAST EXPRESSION SYSTEMS 60
  • 6.6 CELL-FREE EXPRESSION SYSTEMS 61
    • 6.6.1 INCREASING DEMAND FOR RECOMBINANT PROTEINS WILL DRIVE THE GROWTH OF THIS SEGMENT 61
  • 6.7 ALGAL-BASED EXPRESSION SYSTEMS 62
    • 6.7.1 GROWTH IN THE VACCINES MARKET IS SUPPORTING THE GROWTH OF THIS SEGMENT 62

7 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE 63

  • 7.1 INTRODUCTION 64
  • 7.2 REAGENTS 64
    • 7.2.1 REAGENTS ARE THE LARGEST AND FASTEST-GROWING PRODUCTS IN THE PROTEIN EXPRESSION MARKET 64
  • 7.3 EXPRESSION VECTORS 65
    • 7.3.1 EXPRESSION VECTORS ARE FREQUENTLY USED DURING TRANSFECTION 65
  • 7.4 COMPETENT CELLS 66
    • 7.4.1 INCREASING DEMAND FOR THERAPEUTIC PROTEINS TO DRIVE MARKET GROWTH 66
  • 7.5 INSTRUMENTS 67
    • 7.5.1 INSTRUMENTS HELP IN THE EFFICIENT TRANSFER OF GENETIC MATERIALS INTO HOST CELLS 67
  • 7.6 SERVICES 68
    • 7.6.1 RISING DEMAND FOR CUSTOMIZED PROTEINS TO DRIVE THE MARKET FOR SERVICES 68

8 PROTEIN EXPRESSION MARKET, BY APPLICATION 69

  • 8.1 INTRODUCTION 70
  • 8.2 THERAPEUTIC APPLICATIONS 70
    • 8.2.1 THERAPEUTIC PROTEINS ARE USED TO TREAT PATHOLOGICAL CONDITIONS 70
  • 8.3 INDUSTRIAL APPLICATIONS 72
    • 8.3.1 RAPID GROWTH IN THE INDUSTRIAL ENZYMES MARKET IS AN IMPORTANT DRIVER FOR THE GROWTH OF THIS SEGMENT 72
  • 8.4 RESEARCH APPLICATIONS 72
    • 8.4.1 INCREASING INVESTMENTS IN RESEARCH ACTIVITIES WILL DRIVE THE GROWTH OF THIS APPLICATION SEGMENT 72

9 PROTEIN EXPRESSION MARKET, BY END USER 74

  • 9.1 INTRODUCTION 75
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 75
    • 9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF PROTEIN EXPRESSION SYSTEMS 75
  • 9.3 ACADEMIC RESEARCH INSTITUTES 76
    • 9.3.1 INCREASING GOVERNMENT AND PRIVATE FUNDING TO SUPPORT MARKET GROWTH 76
  • 9.4 CONTRACT RESEARCH ORGANIZATIONS 77
    • 9.4.1 INCREASING CLINICAL TRIALS AND OUTSOURCING OF PHARMACEUTICAL MANUFACTURING WILL DRIVE MARKET GROWTH 77
  • 9.5 OTHER END USERS 78

10 PROTEIN EXPRESSION MARKET, BY REGION 79

  • 10.1 INTRODUCTION 80
  • 10.2 NORTH AMERICA 81
    • 10.2.1 US 85
      • 10.2.1.1 The US dominates the global protein expression market 85
    • 10.2.2 CANADA 87
      • 10.2.2.1 Government funding for research and innovation to support market growth 87
  • 10.3 EUROPE 89
    • 10.3.1 GERMANY 93
      • 10.3.1.1 Germany is the largest market for protein expression in Europe 93
    • 10.3.2 FRANCE 95
      • 10.3.2.1 Proteomics research in France is strongly supported by the government 95
    • 10.3.3 UK 97
      • 10.3.3.1 Surge in the prevalence of chronic diseases will drive market growth 97
    • 10.3.4 ITALY 99
      • 10.3.4.1 Growth in this market is driven by the increase in life sciences research projects 99
    • 10.3.5 SPAIN 101
      • 10.3.5.1 Spain has an established network of research centers, universities, and hospitals 101
    • 10.3.6 REST OF EUROPE (ROE) 103
  • 10.4 ASIA PACIFIC 105
    • 10.4.1 CHINA 110
      • 10.4.1.1 Growth in R&D to enhance technological capabilities in the country 110
    • 10.4.2 JAPAN 112
      • 10.4.2.1 Rising geriatric population to support market growth 112
    • 10.4.3 INDIA 114
      • 10.4.3.1 Increasing investments in proteomics research to support market growth 114
    • 10.4.4 AUSTRALIA 116
      • 10.4.4.1 Increasing focus of the healthcare system on precision medicine to offer significant growth opportunities in Australia 116
    • 10.4.5 REST OF ASIA PACIFIC (ROAPAC) 118
  • 10.5 REST OF THE WORLD (ROW) 120
    • 10.5.1 LATIN AMERICA 123
      • 10.5.1.1 Increasing research in the field of stem cells to support market growth in Latin America 123
    • 10.5.2 MIDDLE EAST & AFRICA 125
      • 10.5.2.1 Government investments in the healthcare sector and growing pharmaceuticals industry to drive market growth in the region 125

11 COMPETITIVE LANDSCAPE 127

  • 11.1 INTRODUCTION 127
  • 11.2 MARKET SHARE ANALYSIS 127
  • 11.3 COMPETITIVE LEADERSHIP MAPPING 129
    • 11.3.1 VISIONARY LEADERS 129
    • 11.3.2 INNOVATORS 129
    • 11.3.3 DYNAMIC DIFFERENTIATORS 129
    • 11.3.4 EMERGING COMPANIES 129
  • 11.4 COMPETITIVE SCENARIO 131
    • 11.4.1 KEY DEVELOPMENTS IN THE PROTEIN EXPRESSION MARKET 131

12 COMPANY PROFILES 133

(Business overview, Products and Services offered, Recent developments, SWOT analysis, MNM view)*

  • 12.1 THERMO FISHER SCIENTIFIC, INC. 133
  • 12.2 MERCK KGAA 136
  • 12.3 GENSCRIPT BIOTECH CORPORATION 139
  • 12.4 AGILENT TECHNOLOGIES, INC. 141
  • 12.5 TAKARA BIO, INC. 144
  • 12.6 BIO-RAD LABORATORIES, INC. 146
  • 12.7 LONZA 148
  • 12.8 PROMEGA CORPORATION 150
  • 12.9 NEW ENGLAND BIOLABS 152
  • 12.10 OXFORD EXPRESSION TECHNOLOGIES LTD. 153
  • 12.11 LIFESENSORS 155
  • 12.12 PROTEOGENIX 157
  • 12.13 SYNTHETIC GENOMICS, INC. (SGI) 158
  • 12.14 PEAK PROTEINS LTD. 159
  • 12.15 PROMAB BIOTECHNOLOGIES, INC. 160
  • 12.16 SINO BIOLOGICAL, INC. 161
  • 12.17 LUCIGEN CORPORATION. 162
  • 12.18 ARTES BIOTECHNOLOGY GMBH 163
  • 12.19 JENA BIOSCIENCE GMBH 163
  • 12.20 BIONEER CORPORATION 164
  • 12.21 LENIOBIO GMBH 164

Business overview, Products and Services offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.

13 APPENDIX 165

  • 13.1 DISCUSSION GUIDE 165
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 170
  • 13.3 AVAILABLE CUSTOMIZATIONS 172
  • 13.4 RELATED REPORTS 172
  • 13.5 AUTHOR DETAILS 173

LIST OF TABLES

  • TABLE 1 PROTEINS SYNTHESIZED BY PROTEIN EXPRESSION AND GENETIC ENGINEERING 40
  • TABLE 2 GLOBAL INCIDENCE OF CANCER, BY TYPE (2018) 41
  • TABLE 3 BIOLOGICS AND CELL LINES USED TO PRODUCE THEM 42
  • TABLE 4 GOVERNMENT FUNDING FOR PROTEIN-BASED RESEARCH (2017-2020) 44
  • TABLE 5 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 51
  • TABLE 6 PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION) 52
  • TABLE 7 PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 52
  • TABLE 8 E. COLI SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION) 52
  • TABLE 9 OTHER PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION) 53
  • TABLE 10 MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION) 54
  • TABLE 11 MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 54
  • TABLE 12 CHO SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION) 55
  • TABLE 13 OTHER MAMMALIAN CELL SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION) 55
  • TABLE 14 INSECT CELL EXPRESSION SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION) 56
  • TABLE 15 INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 56
  • TABLE 16 BACULOVIRUS SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION) 57
  • TABLE 17 OTHER INSECT CELL SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION) 57
  • TABLE 18 YEAST EXPRESSION SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION) 58
  • TABLE 19 YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 58
  • TABLE 20 K. LACTIS SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION) 59
  • TABLE 21 SACCHAROMYCES SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION) 59
  • TABLE 22 PICHIA SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION) 60
  • TABLE 23 OTHER YEAST SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION) 61
  • TABLE 24 CELL-FREE EXPRESSION SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION) 61
  • TABLE 25 ALGAL-BASED EXPRESSION SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION) 62
  • TABLE 26 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 64
  • TABLE 27 PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2018-2025 (USD MILLION) 65
  • TABLE 28 PROTEIN EXPRESSION VECTORS MARKET, BY REGION, 2018-2025 (USD MILLION) 66
  • TABLE 29 PROTEIN EXPRESSION COMPETENT CELLS MARKET, BY REGION, 2018-2025 (USD MILLION) 67
  • TABLE 30 PROTEIN EXPRESSION INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION) 67
  • TABLE 31 PROTEIN EXPRESSION SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION) 68
  • TABLE 32 PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 70
  • TABLE 33 THERAPEUTIC PROTEINS & THEIR APPLICATIONS 71
  • TABLE 34 PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2018-2025 (USD MILLION) 71
  • TABLE 35 PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2018-2025 (USD MILLION) 72
  • TABLE 36 PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2018-2025 (USD MILLION) 73
  • TABLE 37 PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 75
  • TABLE 38 PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION) 76
  • TABLE 39 PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION) 77
  • TABLE 40 PROTEIN EXPRESSION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2025 (USD MILLION) 77
  • TABLE 41 PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION) 78
  • TABLE 42 PROTEIN EXPRESSION MARKET, BY REGION, 2018-2025 (USD MILLION) 81
  • TABLE 43 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 82
  • TABLE 44 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 83
  • TABLE 45 NORTH AMERICA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 83
  • TABLE 46 NORTH AMERICA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 83
  • TABLE 47 NORTH AMERICA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 84
  • TABLE 48 NORTH AMERICA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 84
  • TABLE 49 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 84
  • TABLE 50 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 85
  • TABLE 51 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 85
  • TABLE 52 US: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 86
  • TABLE 53 US: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 86
  • TABLE 54 US: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 87
  • TABLE 55 US: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 87
  • TABLE 56 CANADA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 88
  • TABLE 57 CANADA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 88
  • TABLE 58 CANADA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 89
  • TABLE 59 CANADA: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 89
  • TABLE 60 EUROPE: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 90
  • TABLE 61 EUROPE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 90
  • TABLE 62 EUROPE: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 91
  • TABLE 63 EUROPE: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 91
  • TABLE 64 EUROPE: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 91
  • TABLE 65 EUROPE: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 91
  • TABLE 66 EUROPE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 92
  • TABLE 67 EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 92
  • TABLE 68 EUROPE: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 92
  • TABLE 69 GERMANY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 93
  • TABLE 70 GERMANY: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 94
  • TABLE 71 GERMANY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 94
  • TABLE 72 GERMANY: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 94
  • TABLE 73 FRANCE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 96
  • TABLE 74 FRANCE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 96
  • TABLE 75 FRANCE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 96
  • TABLE 76 FRANCE: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 97
  • TABLE 77 UK: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 97
  • TABLE 78 UK: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 98
  • TABLE 79 UK: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 98
  • TABLE 80 UK: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 98
  • TABLE 81 ITALY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 99
  • TABLE 82 ITALY: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 100
  • TABLE 83 ITALY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 100
  • TABLE 84 ITALY: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 100
  • TABLE 85 SPAIN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 101
  • TABLE 86 SPAIN: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 102
  • TABLE 87 SPAIN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 102
  • TABLE 88 SPAIN: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 102
  • TABLE 89 ROE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 103
  • TABLE 90 ROE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 104
  • TABLE 91 ROE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 104
  • TABLE 92 ROE: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 104
  • TABLE 93 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 107
  • TABLE 94 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 107
  • TABLE 95 ASIA PACIFIC: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 107
  • TABLE 96 ASIA PACIFIC: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 108
  • TABLE 97 ASIA PACIFIC: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 108
  • TABLE 98 ASIA PACIFIC: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 108
  • TABLE 99 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 109
  • TABLE 100 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 109
  • TABLE 101 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 109
  • TABLE 102 CHINA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 111
  • TABLE 103 CHINA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 111
  • TABLE 104 CHINA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 111
  • TABLE 105 CHINA: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 112
  • TABLE 106 JAPAN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 113
  • TABLE 107 JAPAN: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 113
  • TABLE 108 JAPAN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 113
  • TABLE 109 JAPAN: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 114
  • TABLE 110 INDIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 115
  • TABLE 111 INDIA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 115
  • TABLE 112 INDIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 115
  • TABLE 113 INDIA: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 116
  • TABLE 114 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 117
  • TABLE 115 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 117
  • TABLE 116 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 117
  • TABLE 117 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 118
  • TABLE 118 ROAPAC: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 119
  • TABLE 119 ROAPAC: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 119
  • TABLE 120 ROAPAC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 119
  • TABLE 121 ROAPAC: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 120
  • TABLE 122 ROW: PROTEIN EXPRESSION MARKET, BY REGION, 2018-2025 (USD MILLION) 120
  • TABLE 123 ROW: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 120
  • TABLE 124 ROW: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 121
  • TABLE 125 ROW: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 121
  • TABLE 126 ROW: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 121
  • TABLE 127 ROW: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2018-2025 (USD MILLION) 121
  • TABLE 128 ROW: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 122
  • TABLE 129 ROW: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 122
  • TABLE 130 ROW: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 122
  • TABLE 131 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 123
  • TABLE 132 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 124
  • TABLE 133 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 124
  • TABLE 134 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 124
  • TABLE 135 MEA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2018-2025 (USD MILLION) 125
  • TABLE 136 MEA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2018-2025 (USD MILLION) 126
  • TABLE 137 MEA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2018-2025 (USD MILLION) 126  
  • TABLE 138 MEA: PROTEIN EXPRESSION MARKET, BY END USER, 2018-2025 (USD MILLION) 126
  • TABLE 139 AGREEMENTS (2017-2020) 131
  • TABLE 140 PRODUCT LAUNCHES (2017-2020) 131
  • TABLE 141 ACQUISITIONS (2017-2020) 131
  • TABLE 142 EXPANSIONS (2017-2020) 132

LIST OF FIGURES

  • FIGURE 1 RESEARCH DESIGN 24
  • FIGURE 2 PRIMARY SOURCES 26
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 27
  • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 28
  • FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC. 28
  • FIGURE 6 DATA TRIANGULATION METHODOLOGY 31
  • FIGURE 7 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020 VS. 2025 (USD MILLION) 33
  • FIGURE 8 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION) 34
  • FIGURE 9 PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION) 34
  • FIGURE 10 PROTEIN EXPRESSION MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 35
  • FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE PROTEIN EXPRESSION MARKET 36
  • FIGURE 12 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH 37
  • FIGURE 13 THERAPEUTIC APPLICATIONS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN PROTEIN EXPRESSION MARKET IN 2019 37
  • FIGURE 14 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE PROTEIN EXPRESSION MARKET FROM 2020 TO 2025 38
  • FIGURE 15 PROTEIN EXPRESSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 39
  • FIGURE 16 DIABETES CASES, BY REGION, 2019 VS. 2045 (MILLION) 40
  • FIGURE 17 GERIATRIC POPULATION (AGED 65 YEARS AND ABOVE), BY REGION, 2019 VS. 2050 42
  • FIGURE 18 NORTH AMERICA DOMINATES THE PROTEIN EXPRESSION MARKET DURING THE FORECAST PERIOD 80
  • FIGURE 19 NORTH AMERICA: PROTEIN EXPRESSION MARKET SNAPSHOT 82
  • FIGURE 20 ASIA PACIFIC: PROTEIN EXPRESSION MARKET SNAPSHOT 106
  • FIGURE 21 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019 127
  • FIGURE 22 COMPETITIVE LEADERSHIP MAPPING: PROTEIN EXPRESSION MARKET 130
  • FIGURE 23 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019) 133
  • FIGURE 24 MERCK KGAA: COMPANY SNAPSHOT (2019) 136
  • FIGURE 25 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2018) 139
  • FIGURE 26 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019) 141
  • FIGURE 27 TAKARA BIO, INC.: COMPANY SNAPSHOT (2019) 144
  • FIGURE 28 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019) 146
  • FIGURE 29 LONZA: COMPANY SNAPSHOT (2019) 148